We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for commissioners and health professionals to make decisions about mental health services and interventions based on data and analysis.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
For the first time, 2- to 5-year-old patients with a certain type of cystic fibrosis could access cystic fibrosis drugs Kaftrio and Kalydeco.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Explanation of terms used in Ofsted's official and national statistical releases.
Information on the programme, including commissioning, quality assurance, education and training.
This information explains what a suspected screening result for cystic fibrosis (CF) means.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Apply for an import certificate to import a medicinal product into the UK for veterinary use.
How to spot Echinococcus multilocularis, what to do if you suspect it and how to prevent its spread.
This service allows hospitals to record incidents of infection after surgery, track patient results and review or change practice to avoid further infections.
All healthcare and laboratory professionals involved in NHS newborn blood spot screening should use this process for cystic fibrosis (CF) referrals.
This document explains the guidelines for laboratories screening newborns for cystic fibrosis (CF) in the UK.
How we are going to deliver our mission to grow the UK economy by providing an IP system that encourages investment in creativity and innovation.
The characteristics, diagnosis, management, surveillance and epidemiology of Pseudomonas aeruginosa.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
This guide sets out what population screening is, how it works, and its limitations.
CASE is a joint programme of strategic research led by DCMS in collaboration with Arts Council England, English Heritage and Sport England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.